FDA Approves Newly Designed Syringe for Lanreotide in GEP-NETs

June 24, 2019 – The FDA has granted an approval to a prefilled syringe for lanreotide, which has been designed to enable healthcare providers to administer the injection easier, for the treatment of adults with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETS). The indications for the treatment remain the same as that of the previously approved prefilled syringe, according to an … (leggi tutto)